Stay updated with breaking news from Zai Lab Forward. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Drug-resistant Acinetobacter baumannii is a growing global health threat and high priority pathogen needing new antibiotics, according to World Health Organization China NMPA approval based on...
SHANGHAI & CAMBRIDGE, Mass., April 02, 2024--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that two poster presentations highlighting ongoing global clinical studies in its oncology pipeline will be presented at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2024 taking place April 5-10, 2024, in San Diego, California.
The METIS trial demonstrated 21.9 months median time to intracranial progression for patients treated with Tumor Treating Fields and supportive care compared to 11.3 months for patients treated with...
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar 13, 2024--
ZL-1310 is an innovative ADC targeting DLL3, a promising therapeutic target in small cell lung cancer and other DLL3+ solid tumors Data will be shared in a poster presentation at the European Lung...